MedKoo Cat#: 597502 | Name: L-Lysine (S)-maleate

Description:

WARNING: This product is for research use only, not for human or veterinary use.

L-Lysine (S)-maleate is used in the preparation of amino acid ionic liquids for use in food and medical field.

Chemical Structure

L-Lysine (S)-maleate
L-Lysine (S)-maleate
CAS#71555-10-7

Theoretical Analysis

MedKoo Cat#: 597502

Name: L-Lysine (S)-maleate

CAS#: 71555-10-7

Chemical Formula: C10H20N2O7

Exact Mass: 280.1271

Molecular Weight: 280.27

Elemental Analysis: C, 42.85; H, 7.19; N, 10.00; O, 39.96

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
L-Lysine (S)-maleate;
IUPAC/Chemical Name
L-lysine compound with (S)-2-hydroxysuccinic acid (1:1)
InChi Key
NWZSZGALRFJKBT-KNIFDHDWSA-N
InChi Code
InChI=1S/C6H14N2O2.C4H6O5/c7-4-2-1-3-5(8)6(9)10;5-2(4(8)9)1-3(6)7/h5H,1-4,7-8H2,(H,9,10);2,5H,1H2,(H,6,7)(H,8,9)/t5-;2-/m00/s1
SMILES Code
N[C@@H](CCCCN)C(O)=O.O=C(O)[C@@H](O)CC(O)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 280.27 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Ivanova EP, Pham DK, Brack N, Pigram P, Nicolau DV. Poly(L-lysine)-mediated immobilisation of oligonucleotides on carboxy-rich polymer surfaces. Biosens Bioelectron. 2004 Jun 15;19(11):1363-70. PubMed PMID: 15093206. 2: Tan-No K, Esashi A, Nakagawasai O, Niijima F, Sakurada C, Sakurada T, Bakalkin G, Terenius L, Tadano T. Nociceptive behavior induced by poly-L-lysine and other basic compounds involves the spinal NMDA receptors. Brain Res. 2004 May 15;1008(1):49-53. PubMed PMID: 15081381. 3: Maćkowiak M, Guzik R, Dudys D, Bator E, Wędzony K. MK-801, a NMDA receptor antagonist, increases phosphorylation of histone H3 in the rat medial prefrontal cortex. Pharmacol Rep. 2013;65(5):1112-23. PubMed PMID: 24399707. 4: Mokrasch LC. Modulation of lysine transport in cultured rat astrocytes and astrocytoma cells. Membr Biochem. 1987-1988;7(4):249-57. PubMed PMID: 3151697. 5: Bergeron M, Mayers P, Brown D. Specific effect of maleate on an apical membrane glycoprotein (gp330) in proximal tubule of rat kidneys. Am J Physiol. 1996 Oct;271(4 Pt 2):F908-16. PubMed PMID: 8898022. 6: Gupta-Agarwal S, Jarome TJ, Fernandez J, Lubin FD. NMDA receptor- and ERK-dependent histone methylation changes in the lateral amygdala bidirectionally regulate fear memory formation. Learn Mem. 2014 Jun 17;21(7):351-62. doi: 10.1101/lm.035105.114. Print 2014 Jul. PubMed PMID: 24939839; PubMed Central PMCID: PMC4061426. 7: Müller M, Reihs T, Ouyang W. Needlelike and spherical polyelectrolyte complex nanoparticles of poly(l-lysine) and copolymers of maleic acid. Langmuir. 2005 Jan 4;21(1):465-9. PubMed PMID: 15620340. 8: Gardner CM, Burke NA, Chu T, Shen F, Potter MA, Stöver HD. Poly(methyl vinyl ether-alt-maleic acid) polymers for cell encapsulation. J Biomater Sci Polym Ed. 2011;22(16):2127-45. doi: 10.1163/092050610X535149. Epub 2010 Nov 9. PubMed PMID: 21067656. 9: Zanchet EM, Longo I, Cury Y. Involvement of spinal neurokinins, excitatory amino acids, proinflammatory cytokines, nitric oxide and prostanoids in pain facilitation induced by Phoneutria nigriventer spider venom. Brain Res. 2004 Sep 17;1021(1):101-11. PubMed PMID: 15328037. 10: Li Q, Clark S, Lewis DV, Wilson WA. NMDA receptor antagonists disinhibit rat posterior cingulate and retrosplenial cortices: a potential mechanism of neurotoxicity. J Neurosci. 2002 Apr 15;22(8):3070-80. PubMed PMID: 11943810. 11: Hayashi H, Mizuguchi H, Miyahara I, Nakajima Y, Hirotsu K, Kagamiyama H. Conformational change in aspartate aminotransferase on substrate binding induces strain in the catalytic group and enhances catalysis. J Biol Chem. 2003 Mar 14;278(11):9481-8. Epub 2002 Dec 17. PubMed PMID: 12488449. 12: Oh KT, Kim D, You HH, Ahn YS, Lee ES. pH-sensitive properties of surface charge-switched multifunctional polymeric micelle. Int J Pharm. 2009 Jul 6;376(1-2):134-40. doi: 10.1016/j.ijpharm.2009.04.021. Epub 2009 Apr 24. PubMed PMID: 19394414. 13: Gloss LM, Kirsch JF. Use of site-directed mutagenesis and alternative substrates to assign the prototropic groups important to catalysis by Escherichia coli aspartate aminotransferase. Biochemistry. 1995 Mar 28;34(12):3999-4007. PubMed PMID: 7696265. 14: Tangsangasaksri M, Takemoto H, Naito M, Maeda Y, Sueyoshi D, Kim HJ, Miura Y, Ahn J, Azuma R, Nishiyama N, Miyata K, Kataoka K. siRNA-Loaded Polyion Complex Micelle Decorated with Charge-Conversional Polymer Tuned to Undergo Stepwise Response to Intra-Tumoral and Intra-Endosomal pHs for Exerting Enhanced RNAi Efficacy. Biomacromolecules. 2016 Jan 11;17(1):246-55. doi: 10.1021/acs.biomac.5b01334. Epub 2015 Dec 8. PubMed PMID: 26616636. 15: Pratt KG, Watt AJ, Griffith LC, Nelson SB, Turrigiano GG. Activity-dependent remodeling of presynaptic inputs by postsynaptic expression of activated CaMKII. Neuron. 2003 Jul 17;39(2):269-81. PubMed PMID: 12873384. 16: Lüthi A, Schwyzer L, Mateos JM, Gähwiler BH, McKinney RA. NMDA receptor activation limits the number of synaptic connections during hippocampal development. Nat Neurosci. 2001 Nov;4(11):1102-7. PubMed PMID: 11687815. 17: Hashimoto K, Mantione CR, Spada MR, Neumeyer JL, London ED. Further characterization of [3H]ifenprodil binding in rat brain. Eur J Pharmacol. 1994 Jan 1;266(1):67-77. PubMed PMID: 7907988. 18: Gao T, Yang C, Zheng YG. Comparative studies of thiol-sensitive fluorogenic probes for HAT assays. Anal Bioanal Chem. 2013 Feb;405(4):1361-71. doi: 10.1007/s00216-012-6522-5. Epub 2012 Nov 9. PubMed PMID: 23138472; PubMed Central PMCID: PMC3548978. 19: West AR, Galloway MP. Endogenous nitric oxide facilitates striatal dopamine and glutamate efflux in vivo: role of ionotropic glutamate receptor-dependent mechanisms. Neuropharmacology. 1997 Nov-Dec;36(11-12):1571-81. PubMed PMID: 9517428. 20: Stefanova HI, East JM, Lee AG. Covalent and non-covalent inhibitors of the phosphate transporter of sarcoplasmic reticulum. Biochim Biophys Acta. 1991 May 7;1064(2):321-8. PubMed PMID: 1827996.